中文 
别名:HRMT1L3应用:IHC
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| Type I protein arginine N-methyltransferases (PRMTs), such as PRMT3, catalyze the formation of asymmetric N(G),N(G)-dimethylarginine (ADMA) residues in proteins (Tang et al., 1998 [PubMed 9642256]). |
| Specification | |
|---|---|
| Aliases | HRMT1L3 |
| Swissprot | O60678 |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthetic peptide of human PRMT3 |
| Formulation | pH7.4 PBS, 0.05% NaN3, 40% Glycerol |
| Application | |
|---|---|
| IHC | 1/50-1/200 |
| ELISA | 1/2000-1/10000 |
 |
The image is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using P11096(PRMT3 Antibody) at dilution 1/30. (Original magnification: ×200) |
 |
The image is immunohistochemistry of paraffin-embedded Human colon cancer tissue using P11096(PRMT3 Antibody) at dilution 1/30. (Original magnification: ×200) |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复